Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gilles Calais

Showing results (11-20 of 59) with videos related to

Pageof 6
Sort By:
Seminars in Oncology|February 11, 2003
Preliminary data of the GORTEC 2000-02 phase III trial comparing intravenous and subcutaneous administration of amifostine for head and neck tumors treated by external radiotherapyEtienne Bardet, Laurent Martin, Gilles Calais, et al.
Journal of the National Cancer Institute|December 19, 2015
Long-term Results of a Multicenter Randomized Phase III Trial of Induction Chemotherapy With Cisplatin, 5-fluorouracil, ± Docetaxel for Larynx PreservationGuillaume Janoray, Yoann Pointreau, Pascal Garaud, et al.
Anticancer Research|October 3, 2022
Outcomes and Side Effects of Preoperative Chemoradiotherapy for Locally Advanced Upper Rectal CancerSandra Chomicki, Sophie Chapet, Moussata Drifa, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|April 2, 2013
A dose escalation study with intensity modulated radiation therapy (IMRT) in T2N0, T2N1, T3N0 squamous cell carcinomas (SCC) of the oropharynx, larynx and hypopharynx using a simultaneous integrated boost (SIB) approachMathieu Leclerc, Philippe Maingon, Marc Hamoir, et al.
Bulletin Du Cancer|April 26, 2012
[Impact of late treatment-related radiotherapy toxicity, depression, and anxiety on quality of life in long-term breast cancer survivors]Paul Brunault, Alain Toledano, Colette Aguerre, et al.
Clinical Genitourinary Cancer|May 13, 2022
Impact of Novel Hormonal Agents (Abiraterone, Enzalutamide) on the Development of Visceral and/or Brain Metastases in Patients With Bone-metastatic Castration-resistant Prostate CancerCédric Pobel, Emeline Laurent, Aline-Marie Florence, et al.
Clinical & Experimental Metastasis|April 24, 2025
Post-operative hypofractionated stereotactic radiotherapy for brain metastases from lung and breast cancer in patients without prior WBRT: a retrospective dose escalation studyNicolas Roquet, Arnaud Beddok, Maxime Loo, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 4, 2010
Positron emission tomography with [18F]fluorodeoxyglucose improves staging and patient management in patients with head and neck squamous cell carcinoma: a multicenter prospective studyMax Lonneux, Marc Hamoir, Hervé Reychler, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 6, 2003
Final results of the 94-01 French Head and Neck Oncology and Radiotherapy Group randomized trial comparing radiotherapy alone with concomitant radiochemotherapy in advanced-stage oropharynx carcinomaFabrice Denis, Pascal Garaud, Etienne Bardet, et al.
Journal of the National Cancer Institute|March 26, 2009
Randomized trial of induction chemotherapy with cisplatin and 5-fluorouracil with or without docetaxel for larynx preservationYoann Pointreau, Pascal Garaud, Sophie Chapet, et al.
Pageof 6

Showing results (11-20 of 59) with videos related to

Sort By:
Pageof 6
Seminars in Oncology|February 11, 2003
Preliminary data of the GORTEC 2000-02 phase III trial comparing intravenous and subcutaneous administration of amifostine for head and neck tumors treated by external radiotherapyEtienne Bardet, Laurent Martin, Gilles Calais, et al.
Journal of the National Cancer Institute|December 19, 2015
Long-term Results of a Multicenter Randomized Phase III Trial of Induction Chemotherapy With Cisplatin, 5-fluorouracil, ± Docetaxel for Larynx PreservationGuillaume Janoray, Yoann Pointreau, Pascal Garaud, et al.
Anticancer Research|October 3, 2022
Outcomes and Side Effects of Preoperative Chemoradiotherapy for Locally Advanced Upper Rectal CancerSandra Chomicki, Sophie Chapet, Moussata Drifa, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|April 2, 2013
A dose escalation study with intensity modulated radiation therapy (IMRT) in T2N0, T2N1, T3N0 squamous cell carcinomas (SCC) of the oropharynx, larynx and hypopharynx using a simultaneous integrated boost (SIB) approachMathieu Leclerc, Philippe Maingon, Marc Hamoir, et al.
Bulletin Du Cancer|April 26, 2012
[Impact of late treatment-related radiotherapy toxicity, depression, and anxiety on quality of life in long-term breast cancer survivors]Paul Brunault, Alain Toledano, Colette Aguerre, et al.
Clinical Genitourinary Cancer|May 13, 2022
Impact of Novel Hormonal Agents (Abiraterone, Enzalutamide) on the Development of Visceral and/or Brain Metastases in Patients With Bone-metastatic Castration-resistant Prostate CancerCédric Pobel, Emeline Laurent, Aline-Marie Florence, et al.
Clinical & Experimental Metastasis|April 24, 2025
Post-operative hypofractionated stereotactic radiotherapy for brain metastases from lung and breast cancer in patients without prior WBRT: a retrospective dose escalation studyNicolas Roquet, Arnaud Beddok, Maxime Loo, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 4, 2010
Positron emission tomography with [18F]fluorodeoxyglucose improves staging and patient management in patients with head and neck squamous cell carcinoma: a multicenter prospective studyMax Lonneux, Marc Hamoir, Hervé Reychler, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 6, 2003
Final results of the 94-01 French Head and Neck Oncology and Radiotherapy Group randomized trial comparing radiotherapy alone with concomitant radiochemotherapy in advanced-stage oropharynx carcinomaFabrice Denis, Pascal Garaud, Etienne Bardet, et al.
Journal of the National Cancer Institute|March 26, 2009
Randomized trial of induction chemotherapy with cisplatin and 5-fluorouracil with or without docetaxel for larynx preservationYoann Pointreau, Pascal Garaud, Sophie Chapet, et al.
Pageof 6